2,3-dinor-thromboxane b2 has been researched along with Substance Withdrawal Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benthin, G; Hillbom, M; Neiman, J; Nowak, J; Numminen, H | 1 |
Feuerstein, TJ; Förstermann, U | 1 |
1 trial(s) available for 2,3-dinor-thromboxane b2 and Substance Withdrawal Syndrome
Article | Year |
---|---|
Increased urinary excretion of a major thromboxane metabolite in early alcohol withdrawal.
Topics: Adult; Alcoholism; Female; Humans; Male; Platelet Count; Substance Withdrawal Syndrome; Thromboxane B2 | 1994 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Substance Withdrawal Syndrome
Article | Year |
---|---|
Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alcoholism; Epoprostenol; Ethanol; Humans; Male; Middle Aged; Prostaglandins E; Prostanoic Acids; Substance Withdrawal Syndrome; Thromboxane B2; Thromboxanes | 1987 |